国内市场综述 高开高走 震荡攀升 周一（5 月 12 日）大盘高开高走，震荡攀升。截至收 盘，上证综指收于 3369.24 点，上涨 0.82%；深成指 收于 10301.16 点，上涨 1.72%；科创 50 上涨 0.49%； 创业板指上涨 2.63%，万得全 A 成交额共 13409 亿元， 较前一日有所上升。 行业方面，30 个中信一级行业有 26 个行业收涨，其 中国防军工、机械、电力设备及新能源涨幅较大，而 农林牧渔、医药、电力设备及新能源则跌幅居前。概 念方面，中船系、航母及大飞机等指数表现活跃。 海外市场综述 美国三大股指大幅收涨，亚马逊涨超 8% 周一（5 月 12 日），美国三大股指大幅收涨，道指涨 2.81%，标普 500 指数涨 3.26%，纳指涨 4.35%。亚马 逊涨超 8%，耐克涨逾 7%，领涨道指。万得美国科技七 巨头指数涨 5.4%，脸书涨近 8%，特斯拉涨超 6%。中 概股普遍上涨，文远知行涨超 27%，世纪互联涨逾 21%。 新闻精要 风险提示 1.稳增长力度不及预期； 2.地缘冲突升级。 分析师：彭竑/钟哲元 登记编码：S1490520090001/ S14905230 ...

万和财富早班车 2025年5月13日 ● 国内金融市场 ● 我们不是资讯的搬运工 而是有态度的发现者 宏观消息汇总 1。中美日内瓦经贸会谈联合声明:双方承诺将于2025年5月14 日前采取一系列举措,包括修改和取消对彼此商品加征的关税, 以及暂停或取消非关税反制措施。 2 商务部：严打战略矿产走私出口,加大口岸查验和打击力度 3。国办发布《新时代的中国国家安全》白皮书,增进国际社会 对中国国家安全的认知和理解 二、行业最新动态 1 5G-A网络商业化加速:智能驾驶、低空经济迎来黄金发展期, 相关个股： 中兴通讯(000063)、中国移动(600941)等 2 王兴兴：很多人形机器人企业爆单了，宇树科技非常缺人, 相关个股：汇川技术(300124)、中控技术(688777)等 3. 荣昌生物(688331)：维迪西妥单抗一线治疗HER2表达的尿路上 皮癌III期临床研究达到主要研究终点 4、新大陆(000997)：公司控股子公司国通星驿与阿里云于近日在 杭州签署深度合作协议,推进Al大模型与公共云合作项目 四、市场回顾及展望 五月十二日(周一),市场昨日小幅高开后一路震荡上行,分 时黄线领涨白线,上证盘中刷新反 ...

Group 1 - The core viewpoint emphasizes the implementation of the "1+10" action plan in Benxi City to stabilize economic growth and promote project development, with a focus on achieving half-year and annual targets [1][2] - Benxi City achieved a total contract value of over 50 million yuan at the Canton Fair, and during the "May Day" holiday, the city received a 29.04% increase in tourists and a 24.08% increase in tourism revenue year-on-year [1] - The "1+10" action plan includes one leading track for party building and ten specific tracks focusing on various sectors such as industry, technology, reform, cooperation, rural revitalization, culture, law, safety, beauty, and welfare [1] Group 2 - The plan aims to provide tailored support for key enterprises, extend the steel industry chain to high-end markets, and support pharmaceutical companies in innovative drug development [2] - The city is targeting a project commencement rate of over 70% for new projects by the end of June, while enhancing investment attraction around eight industrial clusters and sixteen industrial chains [2] - Efforts are being made to accelerate urban infrastructure improvements, including road and lighting upgrades, and to ensure employment services for key groups such as college graduates and migrant workers [2]

Group 1 - The report highlights the core viewpoint that the company, Qii 712 (603712), is a key supplier in military wireless communication, with a focus on independent research and innovation in military communication technology [2] - The company reported a revenue of 216 million yuan in Q1 2025, a decrease of 55.88% year-on-year, and a net profit of -54.02 million yuan, down 440.23% year-on-year [2] - The report anticipates that the company will benefit from the increasing defense spending and the expanding market for military private network wireless communication [2] Group 2 - The report on the pet economy indicates a strong growth momentum, with the fifth TOPS Pet Expo showcasing over 1,200 exhibitors and a 43% increase in visitor numbers compared to the previous year [3] - Exports of pet food from China reached 82,400 tons in the first quarter of 2025, reflecting a year-on-year growth of 19.68% [3] - The report suggests that the pet economy is transitioning from "scale expansion" to "value creation," with leading companies focusing on innovation and brand development [3] Group 3 - The report on Aosaikang (002755) indicates a total revenue of 509 million yuan in Q1 2025, a year-on-year increase of 13.39%, and a net profit of 54.73 million yuan, up 73.50% year-on-year [4] - Aosaikang's SmartKine platform is highlighted as a promising innovation in the field of immunotherapy, aiming to selectively activate the immune system to target tumor cells [4] - The report projects significant revenue growth for Aosaikang, with expected revenues of 1.90 billion, 2.89 billion, and 5.30 billion yuan for 2025, 2026, and 2027 respectively [30] Group 4 - The report on Zhongji Xuchuang (300308) shows a revenue of 6.67 billion yuan in Q1 2025, a year-on-year increase of 37.82%, and a net profit of 1.58 billion yuan, up 56.83% year-on-year [33] - The company is focusing on the development of 800G and 1.6T optical modules, with expectations for increased demand in the second half of 2025 [33] - The report emphasizes the strategic partnership with CarLink to develop vehicle-mounted optical communication modules, aiming to enhance smart vehicle capabilities [33]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600774 股票简称：汉商集团 编号：2025-031 汉商集团股份有限公司 关于2024年度暨2025年第一季度业绩说明会 召开情况的公告 本公司及董事会全体成员保证公告内容不存在虚假记载、误导性陈述或者重大遗漏，并对其内容的真 实、准确和完整承担法律责任。 （2）全覆盖的销售体系。在医药医疗板块，公司根据市场趋势、政策导向、技术应用、客户需求等， 精心培养营销人员，组建了400余人的销售精英团队，遍布全国31个省、市、自治区，触达医院、零售 药店、基层医疗机构、诊所、电商平台等各类销售渠道。营销人员通过提供专业的服务，向市场精准传 达公司产品知识和优势，产品成功落地国内公立及民营医院已超1万家；同时加快零售端和三终端的渠 道布局，目前已覆盖连锁药店门店近30万家，诊所超2万家。建立处方药的学术推广模式和电商业务旗 舰店，以C端为重心，B端为辅助，聚焦核心客户突出重点合作，发挥团队的专业化能力。 （3）专业化的研发平台。公司始终坚持技术创新驱动理念，在药品和医疗器械两个领域建立专业的研 发平台，长期为实现技术研发创新、加快成果转化及产业化、培养研 ...

Group 1 - The core viewpoint of the news is the positive market reaction following the release of the joint statement from the US and China regarding trade talks, leading to a decrease in investor risk aversion [1] - The Shanghai Composite Index rose by 0.82% to 3369.24 points, with significant gains in other indices such as the Shenzhen Component (+1.72%) and the ChiNext Index (+2.63%) [2] - The Hang Seng Index increased by 2.98% to 23549.46 points, marking the highest closing since March 27, with the Hang Seng Tech Index up by 5.16% [4] Group 2 - Traditional safe-haven assets like gold and treasury futures saw declines, with gold prices dropping by 3.5% to $3208.63 per ounce, and 30-year treasury futures falling by 1.31% [5] - The US Treasury yields rose significantly, with the 2-year yield increasing by nearly 12 basis points to 4.00%, the highest since April 9, and the 10-year yield reaching a one-month high of 4.447% [5] - Digital currencies experienced a positive trend, with Bitcoin rising to $104,100 and Ethereum increasing to $2,500, marking a weekly gain of over 40% for Ethereum [9]

证券代码：600056 证券简称：中国医药 公告编号：临 2025-034 号 中国医药健康产业股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 股东大会召开日期：2025年5月28日 ? 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、 召开会议的基本情况 (一)股东大会类型和届次 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 5 月 28 日14 点 30 分 召开地点：北京市丰台区西营街 1 号院 1 区 1 号楼 28 层 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 5 月 28 日 至2025 年 5 月 28 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11 ...

Core Viewpoint - The article discusses the phenomenon of "fake buybacks" in the A-share market, where companies announce buyback plans to artificially inflate their market value, often preceding control transfers, creating a misleading perception of confidence among investors [1][6][9]. Group 1: Buyback Phenomenon - The term "buyback" has become a hot topic in the A-share market, with numerous companies announcing buyback plans weekly, including high-profile executive-led buybacks [1][8]. - Some buyback announcements lead to immediate stock price rebounds and increased trading volumes, but these effects often fade quickly, revealing the superficial nature of the buyback commitments [1][7]. Group 2: Fake Buyback Operations - Goheal's investigation uncovered a case where a company used a buyback announcement to boost its market value, facilitating a control transfer at a higher perceived price, despite minimal actual buyback activity [6][7]. - In a specific case, a pharmaceutical company announced a 500 million yuan buyback plan, resulting in an 18% stock price increase, but only executed 12 million yuan in actual buybacks before a significant shareholder transferred their shares to a state-owned platform [7][8]. Group 3: Market Manipulation and Beneficiaries - The combination of "fake buybacks" and actual control transfers creates a misleading narrative that benefits existing shareholders and new controlling parties, while minority investors are left holding shares in a company with altered control structures [9][10]. - This strategy is characterized as a sophisticated form of market manipulation, which, while legal, obscures the true nature of corporate governance changes [9][10]. Group 4: Identifying Fake Buybacks - Investors and institutions are advised to scrutinize buyback announcements, particularly their timing relative to significant shareholder actions, the actual amounts spent versus promised, and the concentration of buyback activity shortly after announcements [10][11]. - Regulatory bodies are encouraged to focus on the linkage between buyback activities and control changes, ensuring comprehensive and transparent information disclosure to prevent market manipulation [10][11]. Group 5: Reflection on Buyback Regulations - The current buyback mechanisms in the A-share market are more lenient compared to those in the U.S., allowing for potential exploitation by companies, especially given the light penalties for unfulfilled buyback commitments [11][12]. - Goheal suggests that both investors and regulatory bodies should treat the combination of buybacks and control transfers as significant warning signals, emphasizing the need for vigilance in capital market operations [11][12].

《2024年度环境、社会和公司治理(ESG)报告》封面 中国医药秉持"人才为本，质量为核"的核心理念，积极履行人文关怀，帮扶困难员工。公司不断完善质量管理体系，强化全员质量意识，中国医药及下属单 位中21家公司通过29项ISO9001、ISO13485质量管理体系认证，以严苛标准铸就品质标杆，持续以优质服务提升客户满意度。在供应链管理层面，中国医药 依托"客商云"及商贸ERP系统，搭建供应商管理数字化平台，以数字技术赋能管理升级，持续完善供应商管理与沟通机制，推动供应链绿色转型，携手供应 商共建阳光、诚信、可持续的供应生态。此外，中国医药投身公益事业，助力乡村振兴，立足专业优势，优选中药材产品，整合地方特色食品、农副产品以 在全球可持续发展浪潮下，中国医药（600056）健康产业股份有限公司(600056.SH)(以下简称"中国医药")始终秉持"责任治理"与"责任发展"理念，将环境、 社会和公司治理(ESG)融入战略核心。2025年4月26日，公司发布《2024年度环境、社会和公司治理(ESG)报告》(以下简称"本报告")，系统披露了其在绿色 转型、社会责任、治理创新等方面的实践与成效。中国医药立足"科、工、 ...

Group 1: New Stock Market Performance - The average increase of new stocks listed since 2024 is approximately 3.0%, with about 82.9% of new stocks showing positive returns[1] - The average increase for new stocks on the North Exchange is 5.5%, with around 96.2% of new stocks experiencing gains[5] - The average issuance price-to-earnings ratio for new stocks last week was 24.2X, with a subscription success rate of 0.0267%[4] Group 2: Market Trends and Recommendations - The current market is in a transformation window, with significant policy clarity expected to gradually materialize, indicating a potential new active cycle[2] - Caution is advised due to ongoing external disturbances, including geopolitical tensions and tariff negotiations, which may lead to market fluctuations[2] - Focus should be on near-term new stocks that have undergone sufficient adjustment and offer relatively high cost-performance ratios, particularly those benefiting from hot themes or policy expectations[3] Group 3: Upcoming New Stocks - This week, five new stocks are set to complete subscriptions, including one from the Sci-Tech Innovation Board and two from the Growth Enterprise Market[7] - One stock, Guqi Down Material, is expected to start pricing inquiries, being a significant supplier of duck down and goose down materials[8]